Podcasts about Abbott

Chicago Mayor Brandon Johnson and Illinois Gov. JB Pritzker slammed Gov. Greg Abbott for allowing Texas National Guard soldiers to be deployed in the Windy City without their permission. Reporters Benjamin Wermund and Bayliss Wagner join host Jeremy Wallace to break down the tension and dig into how Abbott is responding. Plus, political reporter John Moritz joins the program to assess the latest in the red-hot U.S. Senate race in Texas. Does Wesley Hunt really has a shot in the GOP Primary and why is Jasmine Crockett doing so well in polls on the Democratic side, despite not being in the race? Learn more about your ad choices. Visit megaphone.fm/adchoices

The staff, and special guest Julio Salinas, vent at the end of a long week that consisted of Texas-sized problems: from Gov. Abbott sending Texas National Guard troops to Illinois to Ken Paxton's ego, and threat as the top lawyer and candidate in 2026. Plus, what's concerning us and what's keeping us hopeful in these busy, chaotic times.Thanks for listening! Learn more about Progress Texas at https://progresstexas.org/.

Both DFW International Airport and Dallas Love Field were operating normally Wednesday morning, a day after both were impacted by staffing shortages stemming from the ongoing government shutdown. In other news, Gov. Greg Abbott is threatening to withhold funding for roads from Dallas and other Texas cities if they do not remove rainbow crosswalks. On Wednesday, Abbott said he directed the Texas Department of Transportation to ensure cities and counties erase “any and all political ideologies from our streets,” including symbols and flags; the victim in a fatal Tuesday shooting in Dallas was killed following an argument after she allegedly got upset that a woman did not thank her for holding open a door; and the Dallas Cowboys' reaction to former teammate Rico Dowdle saying they better buckle up for Sunday's game against the Panthers was met with a relaxed response. In Carolina's come-from-behind win over Miami, Dowdle rushed for a career-high 206 yards, earning him NFC Offensive Player of the Week honors. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Pat Cummins' Ashes campaign is in serious doubt after scans revealed his back is still healing. Menners and Damien break down what this means for Australia's summer — from who replaces Cummins to whether Steve Smith should retake the captaincy. They also dissect Mitch Marsh's dominant series in New Zealand, the new white-ball squads for India, and early Sheffield Shield performances shaping the Ashes batting race. The chat rounds out with Ashwin's full-season BBL signing, talk of a New Zealand Big Bash team, Women's World Cup updates, and Harjas Singh's record-breaking 314-run innings. Timecodes (0:56) Cummins' injury update and Ashes implications (2:17) Who replaces him – Doggett, Abbott, Neser, O'Neill (7:00) Should Steve Smith reclaim the captaincy? (11:26) Mitch Marsh's blistering form vs New Zealand (15:51) Australia's ODI & T20 squads named for India (21:58) Sheffield Shield wrap + Ashes batting race (35:07) BBL news: Ashwin for full season | Renegades/Geelong debate (40:05) Women's World Cup + Harjas Singh's 314* and other “Can't Let It Go” stories Cricket Unfiltered Merchandise is Here! We've launched our official Cricket Unfiltered merch store thanks to a brilliant partnership with Exactamundo, a longtime supporter of the show.

Sometimes, cosmic oddities come together in comic ways. For example, Google positions the biography of right-wing Texas governor Greg Abbott right under the one for yesteryear's slapstick comedians, Abbott and Costello.It's almost cruel for Gov. Greg to be juxtaposed with that quick-witted duo, for he's a dour, slow-witted, plutocratic pol, with no perceptible sense of humor. As governor, he has focused on demonizing poor people, rigging elections, and doing favors for moneyed elites. Unsurprisingly, only four out of 10 Texas voters now support him. Yet – don't laugh – in a move of burlesque absurdity, Abbott now says he might choose to become president. Yes, of the US!Filled with pomposity, he recently proclaimed, “I will be guided by God.” Well, maybe so, since the god he faithfully follows is Mammon. Indeed, his major credential for becoming the GOP nominee for prez is that he is a pro at the Pay-to-Play game of using taxpayer money to entice special interests to fund his political career. “You pay me, then I pay you” is his corrupt game plan, which he has used to amass a whopping $87 million for his next election.For example, watchdog group Public Citizen has documented some $3 million that Abbott got from executives of eight corporations. In turn, those eight were given nearly a billion dollars in no-bid state contracts – a 33,000% profit on their donations to Abbott!This is Jim Hightower saying… For high rollers, Abbott is better than a winning Powerball lottery ticket. Buy him, and the Pay-to-Play merry-go-round keeps spinning at taxpayer expense. To fight such big money corruption, go to Public Citizen: citizen.org.Jim Hightower's Lowdown is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit jimhightower.substack.com/subscribe

Stories we're following this morning at Progress Texas:Governor Greg Abbott approved a request by Donald Trump to deploy Texas National Guard troops into both Chicago and Portland, Oregon, under the pretext of protecting ICE agents from Antifa: https://youtu.be/8QFKsX1s_lM?si=Xa-pRwaY6YGgoQ0S...A Trump-appointed federal judge has temporarily blocked that move: https://thehill.com/homenews/administration/5540272-donald-trump-blocked-oregon-guard/California's Prop 50, with which that state's voters will decide whether or not to counter-gerrymander their state against Texas, has seen recent lobbying by Fort Worth State Rep. Nicole Collier in San Francisco: https://www.sfchronicle.com/politics/article/prop-50-fundraising-21066129.phpTexas LGBTQ+ students and their families face multiple obstacles as they try to continue their social groups in spite of new state laws banning them: https://www.nytimes.com/2025/10/05/us/politics/texas-lgbtq-schools.htmlTexas is second only to Florida in the number of books we've banned from our school libraries - here are five of the dumbest new picks: https://www.dallasobserver.com/news/dumbest-books-texas-schools-banned-last-year-40602086/Houston friends! Join Progress Texas in The Heights on Monday October 20 for our H-Town Hits Back live podcast taping event! Tickets and sponsorship opportunities are available now: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://act.progresstexas.org/a/houston2025event⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Thanks for listening! Our monthly donors form the backbone of our funding, and if you're a regular, we'd like to invite you to join the team! Find our web store and other ways to support our important work at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://progresstexas.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Chime In, Send Us a Text Message!Episode 87 Our Guest: Stran Smith 2025 'Draft Pick' for Abbott HeartMates ProgramStran is a legendary tie-down roping cowboy from Childress, Texas. He competed professionally for over 20 years, appearing 11 times at the National Finals Rodeo (NFR), and won the PRCA World Championship in 2008. In 2025 he was inducted into the rodeo Hall of Fame. In this episode, Stran shares his incredible journey from being a professional cowboy to overcoming a life-altering stroke. He discusses the challenges of co-authoring a book, his involvement with the Abbott HeartMates Program and the importance of community support during any type of heart or health related recovery. Stran emphasizes the significance of connection and encouragement for stroke survivors and highlights the HeartMates program as a vital resource for those facing similar challenges. His story is one of resilience, purpose, and the unwavering belief that there is hope and light ahead if you don't give up.More on his stroke: At age 32 he suffered a stroke caused by a previously undetected patent foramen ovale (PFO)—a small opening between the upper chambers of the heart. Doctors initially told him he'd likely never ride again.  He underwent PFO closure using the Abbott Amplatzer Occluder, which enabled his remarkable return to competition and eventual world championship.Abbott HeartMates: In May 2025, Abbott introduced Stran as one of its newest “HeartMates”—heart health champions who share inspiring stories of recovery and resilience. Learn more about Abbott's HeartMates Program and community. https://www.abbott.com/corpnewsroom/healthy-heart/as-abbott-hear Support Our Show! Thank you for helping us to continue to make great content. We appreciate your generosity! DRYYP SaunaFind out more about Mike's new business venture, DRYYP Sauna.Stroke Support Organization (SSO) SurveyIf you support stroke survivors and care partners-please take this survey!Believe in BalanceDavid's Fall Screening and Conditioning Program Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showShow credits:Music intro credit to Jake Dansereau. Our intro welcome is the voice of Caroline Goggin, a stroke survivor and our first podcast guest! Please listen to her inspiring story on Episode 2 of the podcast.Connect with Us and Share our Show on Social:Website | Linkedin | Twitter | YouTube | Facebook | SubstackKnow Stroke Podcast Disclaimer: Our podcast and media advertising services are for informational purposes only and do not constitute the practice of medical advice, diagnosis or treatment. Get Our Podcast News Updates on Substack

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX French drugmaker Sanofi says it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status. The program, originally meant for uninsured diabetes patients, would now include those with commercial insurance or Medicare, the drugmaker said. Patients will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for the fixed monthly price of $35, starting January 1. Lilly and Novo also have similar programs through which they offer insulin products for $35 a month for U.S. patients regardless of whether the patients have insurance. There is no law at work here – the only legislation that has changed the price of insulin came with the Inflation Reduction Act in 2022 with the Medicare cap. Helping lower the cost here, biosimilars hitting the market and the huge profitability for GLP-1 drugs for Novo and Lilly https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-offer-all-insulin-products-35-per-month-us-2025-09-26/ XX A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib (bare-uh-SIT-nib) safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes.. and their diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels.   Baricitinib works by quelling signals in the body that spur on the immune system, and is already approved for treating autoimmune conditions such as rheumatoid arthritis, ulcerative colitis and alopecia, researchers said.   “Among the promising agents shown to preserve beta cell function in type 1 diabetes, baricitinib stands out because it can be taken orally, is well tolerated, including by young children, and is clearly efficacious,” Waibel said. “We are hopeful that larger phase III trials with baricitinib are going to commence soon, in people with recently diagnosed type 1 diabetes as well as in earlier stages to delay insulin dependence,” she added. “If these trials are successful, the drug could be approved for type 1 diabetes treatment within five years.”   Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.   https://www.usnews.com/news/health-news/articles/2025-09-23/pill-effective-in-slowing-type-1-diabetes-progression XX An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. The Drug, called ATG, is currently used together with other medicines to prevent and treat the body from rejecting a kidney transplant. It can also be used to treat rejection following transplantation of other organs, such as hearts, gastrointestinal organs, or lungs. The researchers studied 117 people aged five to 25, who'd been diagnosed with type 1 diabetes within the past three to nine weeks. The participants were from 14 centers across eight European countries and were randomized to be given different doses of ATG (0.1, 0.5, 1.5, or 2.5 mg/kg) or a placebo. ATG was given as a two-day intravenous (IV) infusion. The main goal was to see how well the pancreas could still make insulin after 12 months, measured by C-peptide levels during a special meal test. C-peptide is released into the blood along with insulin by the pancreas.   The findings are promising, showing that ATG, even at a relatively low dose, can slow the loss of insulin-producing cells in young people newly diagnosed with type 1 diabetes. The lower dose also caused fewer side effects, making it a more practical option. https://newatlas.com/disease/antithymocyte-globulin-newly-diagnosed-type-1-diabetes/     XX The FDA has delayed its feedback on Lexicon Pharmaceuticals' application to bring Zynquista (sotagliflozin) to people with type 1 diabetes. The agency had planned to respond this month but will now wait until the fourth quarter after reviewing new data from ongoing studies. Zynquista, an oral drug meant to be used with insulin, has already been approved for heart failure (marketed as Inpefa). But in type 1 diabetes, it faces safety concerns: last year an FDA advisory committee voted 11–3 that its benefits don't outweigh the increased risk of diabetic ketoacidosis (DKA). The FDA later issued a complete response letter rejecting the drug. Lexicon is still pushing forward, hoping its additional submissions will strengthen Zynquista's case for type 1 diabetes approval. https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay     XX A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide. A new study found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition.   G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test—which diagnoses and monitors diabetes—appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment.   The study found men with G6PD deficiency are at a 37% higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes.   "This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late." https://medicalxpress.com/news/2025-09-hidden-genetic-delay-diabetes-diagnosis.html XX Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli® would become the first once-weekly basal insulin available in the United States, providing an alternative to daily basal insulin injections for adults living with type 2 diabetes.   The resubmission is based on results from the ONWARDS type 2 diabetes phase 3a program for once-weekly Awiqli® which is comprised of five randomized, active-controlled, treat-to-target clinical trials in approximately 4,000 adults with type 2 diabetes. The clinical program evaluated Awiqli® vs. daily basal insulin and the primary endpoint in these trials was change in A1C from baseline.1-5 Awiqli® is approved in the EU, along with 12 additional countries. In addition, regulatory filings have been completed in several other countries, with further regulatory decisions expected in 2025. XX Interesting news from Sequel Med Tech – they've signed an agreement with Arecor to pair the twiist pump with AT278 an ultra-concentrated (500U/mL), ultra-rapid insulin in development. They also have a deal with Medtronic to develop insulin for new pumps. This insulin isn't yet approved, it's 5 times stronger than standard fast acting  it's hoped that a clinical study will begin next year. Arecor says its insulin could potentially be the only option capable of enabling and catalyzing the next generation of longer-wear and miniaturized automated insulin delivery systems.   https://www.drugdeliverybusiness.com/sequel-arecor-develop-rapid-insulin-twiist/ XX Tandem Diabetes Care announes its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United States (U.S.).   – The t:slim X2 insulin pump with Control-IQ+ technology is now cleared for use with Lyumjev for people with type 1 diabetes ages 2 and above and all adults with type 2 diabetes. The companies are continuing to work toward securing Lyumjev compatibility for the Tandem Mobi pump. https://hitconsultant.net/2025/09/29/tandem-diabetes-cares-tslim-x2-pump-cleared-for-use-with-lillys-ultra-rapid-lyumjev-insulin/ XX You can now place your order for the MiniMed™ 780G system with the Instinct sensor, made by Abbott. And if you are already a MiniMed 780G user, you can place an upgrade order today. ​This is a 15 day wear sensor, with no transmitter or overtape required. It looks the same at other Abbot sensors such as the Libre but is proprietary to Medtronic. Shipments are scheduled to start in November.   ​ https://www.drugdeliverybusiness.com/medtronic-launches-minimed-780g-instinct-abbott/   XX The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates. ,   The study estimates that T1D will affect 9.5 million people globally in 2025 (up by 13% since 2021), and this number is predicted to rise to 14.7 million in 2040. However, due to lack of diagnosis and challenges in collecting sufficient data, the actual number of individuals living with T1D is likely much higher, researchers say.   In fact, they estimate that there are an additional 4.1 million 'missing people' who would have been alive in 2025 if they hadn't died prematurely from poor T1D care, including an estimated 669,000 who were not diagnosed. This is particularly true in India, where an estimated 159,000 people thought to have died from missed diagnoses. The study predicts that 513,000 new cases of T1D will be diagnosed worldwide in 2025, of which 43% (222,000) will be people younger than 20 years old. Finland is projected to have the highest incidence of T1D in children aged 0-14 years in 2025 at around 64 cases per 100,000. The substantial increases in T1D forecasts between 2025 and 2040 underscore the urgent need for action. As co-author Renza Scibilia from Breakthrough T1D explains, "Early diagnosis, access to insulin and diabetes supplies, and proper healthcare can bring enormous benefits, with the potential to save millions of lives in the coming decades by ensuring universal access to insulin and improving the rate of diagnosis in all countries."   The authors note some important limitations to their estimates, including that while the analysis uses the best available data, predictions are constrained by the lack of accurate data in most countries-highlighting the urgent need for increased surveillance and research. They also note that data on misdiagnosis and adult populations remain limited, and the analysis assumes constant age-specific incidence and mortality over time. Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Future updates are expected to improve as new data become available and applied. https://www.news-medical.net/news/20250919/New-study-warns-of-millions-of-undiagnosed-and-missing-people-with-type-1-diabetes.aspx XX A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy. Researchers estimate that as much as 40% of all people with diabetes also have diabetic retinopathy — a potentially blinding eye condition caused by blood vessel damage in the eye's retina. There is currently no cure for diabetic retinopathy. The condition is often managed through injections of anti-VEGF medications into the eye, surgery, and blood sugar monitoring and control. For this lab-based study, researchers used samples of human retinal endothelial cells that were treated with different concentrations of semaglutide. The cells were then placed in a solution with both a high glucose level and high level of oxidative stress — where there is an imbalance of antioxidants and free radicals — for 24 hours.   Past studies show that oxidative stress plays a role in the formation of diabetic retinopathy.   At the study's conclusion, researchers found that the retinal cells treated with semaglutide were twice as likely to survive than cells that were untreated. Additionally, the treated cells were found to have larger stores of energy.   Scientists also found that three markers of diabetic retinopathy were decreased in the semaglutide-treated retinal cells. First, the levels of apoptosis — a form of cell death — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The production of the free radical mitochondrial superoxide decreased from about 90% to about 10% in the treated retinal cells.   Researchers also found the amount of advanced glycation end-products — harmful compounds that can collect in people with diabetes and are known to cause oxidative stress — also decreased substantially.   Lastly, scientists reported that the genes involved in the production of antioxidants were more active in the semaglutide-treated cells when compared to untreated cells. Researchers believe this is a sign that semaglutide may help repair damage to the retinal cells.   “Our study did not find that these drugs harmed the retinal cells in any way — instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher at the National and Kapodistrian University in Greece, and lead author of this study, said in a press release.   “Excitingly, these drugs may be able to repair damage that has already been done and so improve sight. Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.” https://www.medicalnewstoday.com/articles/ozempic-semaglutide-may-help-protect-against-diabetes-related-blindness-retinopathy   XX Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. This one is tricky – it's called a needle free CGM but it also says it uses micro needles. By the way, De Novo isn't exactly the same as what we think of for FDA approval for medical devices. It's not as rigorous but it's a streamlined route for novel, low to moderate risk devices with no existing equivalent. We'll see how this one turns out. https://www.hmenews.com/article/biolinq-s-multi-function-biosensor-receives-fda-de-novo-classification

On this week's bumper episode of Marathon Talk, we look back on a punishing day in Berlin as Sabastion Sawe and Rosemary Wanjiru won the BMW BERLIN-MARATHON. We also have news of a PB time for Sted Sarandos, your new favourite celebrity marathon runner. Our first guest on the show is Team GB athlete Phily Bowden, who is preparing for next week's Bank of America Chicago Marathon, and offered us real insight into her training plan and how she prepares for a Major event. And to close the show, we are so pleased to be joined by Abbott Senior Vice President of Global Marketing and External Affairs Melissa Brotz to talk to us about Team Abbott, 10 years of the Abbott and World Marathon Majors partnership, and much more.   In this episode of Marathon Talk: 5:32 - Martin and Deena talk about the BMW BERLIN-MARATHON. 10:22 - Sted Sarandos is the man everyone wanted to see in Berlin. But just who is this mysterious sub-3:00 marathoner? 12:37 - We preview the Bank of America Chicago Marathon 15:23 - We meet Phily Bowden and hear about her preparation for next week's Bank of America Chicago Marathon 39:50 - Melissa Brotz, Senior Vice President of Global Marketing and External Affairs at Abbott, joins us to talk all about a partnership that is now about to enter its 11th year. ‍Links & references‍ Abbott World Marathon Majors https://www.worldmarathonmajors.com/ https://www.instagram.com/wmmajors/‍ https://www.tiktok.com/@marathontalk Martin Yelling https://www.instagram.com/martinyelling/ Deena Kastor https://www.instagram.com/deena8050/ Phily Bowden https://www.instagram.com/philybowden/ https://www.youtube.com/@philybowden  

For this episode of HaHaHalloween, we wanted to throw things back a ways to some of the earliest horror parodies. What better than Abbott and Costello Meet Frankenstein, a monster mashup that started the craze of the comedy duo meeting various Universal monsters. We talk about the appeal of this Avengers of horror, the slapstick comedy the two perfected, and Martin's disdain for Bela Lugosi?!Approximate timeline0:00-15:00 Intro15:00-25:00 Beer talk25:00-end Abbott and Costello Meet FrankensteinHaHaHalloween continues all Halloween season!

GET THE FULL EPISODE AT patreon.com/extended_clip The season is upon us, ladies and germs. The 2nd Annual Baby Bobby Franco Halloween Mindset Takeover IS HERE. First up, we're talking about Abbott & Costello Meet Frankenstein. What happens when two vaudevillian bozos smash into the world of Universal's monsters? Then, picking up where we left off last year, we indulge in a seasonal taste test, or, treat chat, or, "THE CANDY LINEUP."

In this episode we speak with three runners from Team Abbott — a community of runners who have faced serious health challenges but didn't let those challenges define them! [powerpress] About Our Guests Elizabeth Pehota (Boston, MA): Three days out from running the 2022 Berlin Marathon, Elizabeth Pehota experienced a feeling of pins and needles in her hands, feet and thighs, and an unnatural resistance while running. Soon after, she was diagnosed with Multiple Sclerosis (MS), a chronic, unpredictable disease of the central nervous system. As someone who shares her daily life on social media, Elizabeth, @healthy_cheers on Instagram, only recently opened up about her diagnosis, but has already formed relationships with other MS patients around the world. Elizabeth is an Abbott World Marathon Major Six Star Finisher and received her seventh star in Sydney. Ed Barnes (Douglas, MA): Ed was born with a congenital heart condition and at age 15 he started to experience frequent dizziness - to the point of nearly passing out - leading him to undergo open heart surgery to receive an Abbott artificial aortic heart valve. This year, after completing the Boston Marathon, Ed became the first person with an artificial heart valve to finish all seven Abbott World Marathon Majors.   Mary Tawney Suarez (Fullerton, CA): Just before the pandemic, Mary started experiencing seizures and was diagnosed with Epilepsy and a brain cyst. One year later, she started experiencing back pain and numbness in her legs, which was revealed to be the degeneration of the cerebral and lower part of her spine. Despite these obstacles, Mary has continued running, and just finished the Berlin Marathon. [box] Links Mentioned in This Episode Run Coaching. Work with an expert MTA running Coach. MetPro.co -For the first time ever, MetPro is offering MTA listeners a full 30-day experience for just $95 with absolutely no strings attached! See what it's like working with your own metabolic coach. Limited to the first 30 people. AG1 Next Gen has new flavors: new flavors: Citrus, Tropical, and Berry. Get a free Welcome Kit with your first order which includes 5 AG1 Travel Packs, a shaker bottle, metal canister, and a bottle of AG Vitamin D3+K2. The Virginia Credit Union River City Half -March 7 in Richmond, Virginia. Drury Hotels -Get 10% off your stay with our link or use the code RN2025. Team Abbott -a community of runners, many of whom have overcome health challenges, who are committed to inspiring others through their running journeys. To submit your story for a chance to join Team Abbott, visit abbott.com/marathons. [/box]

Throughout three years of school, Rae Malgregor had been perfectly pliant, perfectly compliant to all the demands placed on her. But now, on the eve of graduation, she couldn't go on with the mask of artificiality and the air of perfection. She had been chasing this nursing job three whole years, but there was just no wag to it! The Superintendent was stunned. Her best student! The Senior Surgeon was all grey granite business and livid that his time was being taken up with a hysterical nurse! And yet, though he wouldn't have admitted it to anyone, especially himself, his interest was piqued. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Throughout three years of school, Rae Malgregor had been perfectly pliant, perfectly compliant to all the demands placed on her. But now, on the eve of graduation, she couldn't go on with the mask of artificiality and the air of perfection. She had been chasing this nursing job three whole years, but there was just no wag to it! The Superintendent was stunned. Her best student! The Senior Surgeon was all grey granite business and livid that his time was being taken up with a hysterical nurse! And yet, though he wouldn't have admitted it to anyone, especially himself, his interest was piqued. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Throughout three years of school, Rae Malgregor had been perfectly pliant, perfectly compliant to all the demands placed on her. But now, on the eve of graduation, she couldn't go on with the mask of artificiality and the air of perfection. She had been chasing this nursing job three whole years, but there was just no wag to it! The Superintendent was stunned. Her best student! The Senior Surgeon was all grey granite business and livid that his time was being taken up with a hysterical nurse! And yet, though he wouldn't have admitted it to anyone, especially himself, his interest was piqued. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Throughout three years of school, Rae Malgregor had been perfectly pliant, perfectly compliant to all the demands placed on her. But now, on the eve of graduation, she couldn't go on with the mask of artificiality and the air of perfection. She had been chasing this nursing job three whole years, but there was just no wag to it! The Superintendent was stunned. Her best student! The Senior Surgeon was all grey granite business and livid that his time was being taken up with a hysterical nurse! And yet, though he wouldn't have admitted it to anyone, especially himself, his interest was piqued. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Throughout three years of school, Rae Malgregor had been perfectly pliant, perfectly compliant to all the demands placed on her. But now, on the eve of graduation, she couldn't go on with the mask of artificiality and the air of perfection. She had been chasing this nursing job three whole years, but there was just no wag to it! The Superintendent was stunned. Her best student! The Senior Surgeon was all grey granite business and livid that his time was being taken up with a hysterical nurse! And yet, though he wouldn't have admitted it to anyone, especially himself, his interest was piqued. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über einen Gamechanger-Deal, Wall-Street-Rekorde trotz Shutdown und das fulminante Börsendebüt von Fermi. Außerdem geht es um Pfizer, Merck, Eli Lilly, Novo Nordisk, Vertex, Regeneron, Thermo Fisher, Repligen, Danaher, Boston Scientific, Abbott, Intuitive Surgical, Bayer, Merck, Salzgitter, Thyssenkrupp, Bitcoin, Solana, Ether, Sartorius, Palantir Technologies, Thales, L3Harris Technologies, RTX, Kratos Defense & Security Solutions, AeroVironment, DroneShield, Elbit Systems, Electro Optic Systems, Saab AB, Hensoldt, Mercury Systems, QinetiQ, Chemring Group, Cohort, Exail Technologies, Rocket Lab, Iridium Communications, BlackSky Technology, Electro Optic Systems, Leidos Holdings, CACI International, Parsons, Telos Corp, Leidos, SAIC, QinetiQ, Parsons VanEck Space Innovators ETF (WKN: A3DP9J), Invesco Defence Innovation ETF (WKN: A40J95), Global X Defence Tech ETF (WKN: A40E7A), Droneshield, Palantir, Red Cat Holdings. Wir freuen uns über Feedback an aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article104636888/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Let the Wild Gods Rise.  Easy to say and harder to do - but if you were offered a portal, a way to step into the other-worlds, to reconnect with all that we have been and could be, would you take it? If you're listening to this, you are likely steeped in the mechanical world of our culture - but it doesn't have to be like this.  The other worlds are alive, present…wild—and just within reach. All we need are doorways, places where the veils between the worlds grow thinner and then route maps to take us to—and through—them. There are many of these: some of us have places where we go to sit, day after week after month after year; places we walk where the lapwings fly or the toads grumble or the lichens coat the rocks. Some of us dance, or sing, or hold spaces for each other to find the endless re-creation of the web in the inter-becoming moment, the dependent co-arising of the magic of life. Many of us go to books and it's one of these we're visiting today: Wild Folk by Jackie Morris and Tamsin Abbott is a work of art, a delight on so many levels—and it's explicitly a portal to the wild at the heart of the world. I'm fairly sure I don't need to introduce these two amazing women, but just in case: Jackie Morris is an artist, illustrator and wordsmith. Alone or in collaboration has written & illustrated over forty books, including classics such as The Snow Leopard, Song of the Golden Hare, and East of the Sun, West of the Moon. More recently, she and Robert Macfarlane co-created The Lost Words, and The Lost Spells, and I'm delighted to say they are working on new book on birds, which is due to come out soon.Tamsin Abbott has been creating painted stained-glass panels for over twenty years. Herwork is influenced by this ancient land and how we are connected to it: the hills, the woods, the plants, birds and animals that live alongside us and the world of myths and fairytales that we have spun around it. She has appeared on BBC Countryfile, appeared in many of this country's foremost magazines and exhibited in our leading galleries. As you'll hear, Jackie and Tamsin had been friends for many years before the seed of Wild Folk finally took root at a residency in the wilds of Exmoor. The result is a work of pure magic.  Come along with us and let's explore the what and the how and the where and the who of this astonishing act of co-creation. Where you'll find WILD FOLK in the UK https://www.jackiemorris.co.uk/where-the-wild-folk-books-are/Tamsin's website https://www.tamsinabbott.co.uk/Tamsin on Instagram https://www.instagram.com/tamsintheshed/Tamsin on Facebook https://www.facebook.com/Tamsin-Abbott-260979701880/Jackie's website https://www.jackiemorris.co.uk/Jackie on Instagram https://www.instagram.com/jackiemorrisartist/Jackie on Facebook https://www.facebook.com/JackieMorrisPaints/What we offer: Accidental Gods, Dreaming Awake and the Thrutopia Writing Masterclass If you'd like to join our next Open Gathering offered by our Accidental Gods Programme it's  'Dreaming Your Death Awake' (you don't have to be a member) it's on 2nd November - details are here.If you'd like to join us at Accidental Gods, this is the membership where we endeavour to help you to connect fully with the living web of life. If you'd like to train more deeply in the contemporary shamanic work at Dreaming Awake, you'll find us here. If you'd like to explore the recordings from our last Thrutopia Writing Masterclass, the details are here

Stories we're following this morning at Progress Texas:Governor Abbott faces multiple issues that could make him vulnerable in 2026, including his inconsistencies related to on-campus free speech: https://www.texasobserver.org/greg-abbott-free-speech-charlie-kirk-universities/...His engineering of attacks on public school teachers who failed to sufficiently grieve the death of Charlie Kirk: https://www.texastribune.org/2025/09/30/texas-investigation-teachers-charlie-kirk-free-speech/?_bhlid=29b43cb8833938b9d33be0c7e1d0dbf7be829e1f...And a growing "pay to pay" scandal, in which Abbott has apparently channeled almost $1 billion (with a B) in no-bid state contracts to companies whose executive have made large contributions to his campaign fund: https://www.newsbreak.com/raw-story-2096750/4254968215000-pay-to-play-donors-to-texas-gov-s-pac-received-nearly-1-billion-in-state-contracts...Could Austin State Rep. Gina Hinojosa be next to throw in to challenge Abbott? https://www.axios.com/local/austin/2025/09/26/gina-hinojosa-austin-democrat-campaign-texas-governorEven as they run ICE recruitment commercials on ESPN, Disney has taken a massive financial hit as a result of the Jimmy Kimmel suspension from ABC: https://www.engadget.com/entertainment/streaming/disney-reportedly-lost-17-million-paid-subscribers-in-the-week-after-suspending-kimmel-201615937.html...Disney shareholders and journalists are demanding internal records on how the Kimmel suspension was decided, potentially resulting in lawsuits: https://deadline.com/2025/09/kimmel-disney-shareholders-deadline-legal-threat-1236565674/Houston friends! Join Progress Texas in The Heights on Monday October 20 for our H-Town Hits Back live podcast taping event! Tickets and sponsorship opportunities are available now: ⁠⁠⁠⁠⁠⁠⁠⁠https://act.progresstexas.org/a/houston2025event⁠⁠⁠⁠⁠⁠⁠⁠Thanks for listening! Our monthly donors form the backbone of our funding, and if you're a regular, we'd like to invite you to join the team! Find our web store and other ways to support our important work at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://progresstexas.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Are you a night owl or a morning lark?For many of us the traditional working day just doesn't suit our circadian rhythms. We're called into a meeting or slumped over a desk at 8am but hyper focused as we're about to leave the office and head home. What if work took our biological clocks into account?In this episode I am joined by Camilla Kring, author of Chrono leadership. We talk about the costs of rigidity in work patterns, and what it takes to develop smarter, more flexible arrangements.Camilla's ideas are revolutionary; she talks about taking the bias away from the 5am club and creating better conditions in the workplace for all. Surely that is something we would all want to get behind.So, when do you perform at your best during the day?“Synchronise your work, family, and biological rhythms for real performance.” - CamillaYou'll hear about:·      How circadian rhythms dictate our natural sleep and wake cycles.·      Why understanding your chronotype can enhance productivity.·      The fact most people are not morning persons, yet workplaces favour early risers.·      How living out of sync with your internal clock can harm health.·      Flexibility in work hours can lead to higher productivity and well-being.·      Trust in employees being crucial for implementing flexible work schedules.·      Why synchronising work and family rhythms can improve life quality. More about Camilla:Camilla Kring, as the founder of Super Navigators, has dedicated the last 20 years to helping individuals navigate their lives and organisations create flexible and inclusive work cultures that accommodate different chronotypes and family structures. She has worked across Europe, China, Latin America and the Middle East with companies including Abbott, Medtronic, Roche and Novo Nordisk.Camilla's insights have been featured in the New York Times, the BBC and the Guardian. She is the author of six books and a TEDx speaker. She holds a Master of Science in Engineering and a PhD in work-life balance from the Technical University of Denmark (DTU). Resources:• Profile: https://www.camillakring.com/about-camilla/ • Book - Chronoleadership: https://www.camillakring.com/books/ • Supernavigators services: https://www.supernavigators.com/   My resources:Try my High-stakes meetings toolkit (https://bit.ly/43cnhnQ) Take my Becoming a Strategic Leader course (https://bit.ly/3KJYDTj)Sign up to my Every Day is a Strategy Day newsletter (http://bit.ly/36WRpri) for modern mindsets and practices to help you get ahead.Subscribe to my YouTube channel (http://bit.ly/3cFGk1k) where you can watch the conversation.For more details about me:●      Services (https://rb.gy/ahlcuy) to CEOs, entrepreneurs and professionals.●      About me (https://rb.gy/dvmg9n) - my background, experience and philosophy.●      Examples of my writing https://rb.gy/jlbdds)●      Follow me and engage with me on LinkedIn (https://bit.ly/2Z2PexP)●      Follow me and engage with me on Twitter (https://bit.ly/36XavNI)

Escucha el podcast del programa Sobre Ruedas con Harold Abbott a través de Súper 7 FM, en Santo Domingo, República Dominicana correspondiente al martes 30-septiembre-2025.

If you would like more information about the resources Mona offers through Neurodiverse Love you can check out her website at: Neurodiverselove.com——————————————————————————The process of self-discovery & acceptance as an autistic or neurodivergent person can be riddled with external and internal challenges. These challenges show up in our relationships with self & others but are navigable with the right supports and resources in place. This episode is a presentation from the 2025 Neurodiverse Love Conference and includes key practices for enhancing self-acceptance and appreciation, through a compassion-focused lens, that can help us improve our connections with the self and others.Ali Cunningham Abbott, PhD, LMHC, QS has worked in higher education and mental health settings for the last 17 years. She is the Program Director & an Associate Professor in the CACREP-accredited Clinical Mental Health Counseling program at Lynn University in Boca Raton, Florida. Prior to academia, she worked at Florida Atlantic University as the Assistant Director for the Center for Autism & Related Disabilities (CARD) where she provided individual, couples, and family direct support and consultative services to the community. Currently, she provides individual counseling for adolescents and adults at the Center for the Treatment of Anxiety & Mood Disorders. Cunningham has presented on and published a book, book chapters and academic articles related to various topics including autism supports & advocacy, mental health first aid, counselor career preparation, and on advocacy for BIPOC, queer & trans communities. You can reach Ali at the link below:Clinical Mental Health Counseling Program

Abbott & Costello 42-05-11 Lou Substitutes For Joe Dimaggio

Click to Subscribe: https://bit.ly/Youtube-Subscribe-SoapDirt Young and the Restless 2-week spoilers for Sept 29 - Oct 10, 2025 witness a myriad of twists and turns. Key characters such as Sally Spectra (Courtney Hope), Adam Newman (Mark Grossman), and Billy Abbott (Jason Thompson). Billy approaches Jack Abbott (Peter Bergman) with a request for funding, which Jack declines due to trust issues. Meanwhile, Victor Newman (Eric Braeden) and Jack contemplate working together to bring down Cane Ashby (Billy Flynn), but Nikki Newman (Melody Thomas Scott) warns Victor against betrayal.  Spoilers for Young and Restless have Nikki and Victor then fill in Nick Newman (Joshua Morrow) and Victoria Newman (Amelia Heinle) about the truce, while concerns are raised about the possible negative impact of Jill Abbott's (Jess Walton) arrival to Genoa City on the situation. Claire Grace Newman (Hayley Erin) breaks up with Kyle Abbott (Michael Mealor), setting the stage for her departure to LA with Holden Novak (Nathan Owens). Sally and Audra Charles (Zuleyka Silver) have a discussion about the future of Abbott com, leading to more tension.  Y&R spoilers shock when Sally conceals a secret from Billy, and Tessa Porter (Cait Fairbanks) defends herself against Sharon Newman's (Sharon Case) questions about Mariah Copeland (Camryn Grimes). Further, Lauren Fenmore (Tracey Bregman) grows concerned about Michael Baldwin's (Christian Jules Leblanc) old habits resurfacing. Jill returns to Genoa City, and Victor and Jack initiate their plan against Cane. Nick and Sharon plan a trip to LA, leaving Adam worried about the potential fallouts of Victor and Jack's truce.  Young and Restless spoilers focus on Billy's struggles with his emotions, while Sharon and Nick embark on their LA adventure. New characters are introduced, and Sally deals with Billy's antics. Phyllis Summers (Michelle Stafford) finds herself desperate for Cane's attention the weeks of 09/29-10/10, 2025. You are listening to Belynda from Soap Dirt. The most listened to podcast for soap operas. Visit our Young and the Restless section of Soap Dirt: https://soapdirt.com/category/young-and-the-restless/ Listen to our Podcasts: https://soapdirt.podbean.com/ Check out our always up-to-date Young and the Restless Spoilers page at: https://soapdirt.com/young-and-the-restless-spoilers/ Check Out our Social Media... Twitter: https://twitter.com/SoapDirtTV Facebook: https://www.facebook.com/SoapDirt Pinterest: https://www.pinterest.com/soapdirt/ TikTok: https://www.tiktok.com/@soapdirt Instagram: https://www.instagram.com/soapdirt/

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Rob Abbott, CEO of ISPOR, explains how startup and early-stage clinical drug development companies benefit from conducting health economics and outcomes research (HEOR), and not just with patients and commercial payers. HEOR, viewed as a strategic lever as opposed to a compliance exercise, can help answer investor questions about market differentiation, pricing pathways, and real world product validation. Abbott talks about the value of cost-of-illness studies, burden-of-disease analyses, and payer landscape assessments, and how AI, real world evidence, and patient-centered research can improve drug and trial design and accelerate market access.       Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

Costello has learned he just inherited a fortune. As mayor of Sherman Oaks, Abbott plans to help him invest it. Costello shows off what he knows about the newspaper industry.…

The 10 plagues are not merely means of Israel's liberation, they serve as God Almighty's pursuit that ALL PEOPLE would know him. Journey with us this weekend as we explore God's Sovereignty through the 10 Plagues.

Synlait has confirmed the sale of its loss-making factory at Pōkeno to US company, Abbott. The infant-formula company is selling the site and related assets for $307 million, and will use the proceeds to pay down debt. Harbour Asset Management expert Shane Solly unpacks the data further. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Lisa Ann Walters from ABC's smash hit Abbott Elementary joined us ...-Lisa is a great cook-She was just at the Emmys - she saw Nate's opening bit, but could NOT hear it-Abbott coming back... And so much more (she is just FUNNY) To subscribe to The Pete McMurray Show Podcast just click here

Jaguar Enthusiast Magazine has teamed up with our heritage partners, The Jaguar Daimler Heritage Trust, to track the human stories behind one of Jaguar's best-selling model ranges that was in production for nearly a quarter of a century!Launched in 1975 as the successor to the legendary E-type, the XJS celebrates 50 years this year. So, buckle up — we're going to explore the highs, lows, and lasting impact of Jaguar's misunderstood masterpiece: the XJS.Ed began his career at Jaguar in the 1970s, where he worked as a development engineer on the company's road cars and competition projects. His work spanned chassis, suspension, and performance development, giving him a front-row seat as Jaguar navigated one of the most fascinating and challenging chapters in its history. After his time at Jaguar, Ed went on to found Abbott Racing, a specialist engineering company that built a reputation for extracting performance and reliability from both road and racing machinery. That blend of hands-on engineering expertise and entrepreneurial drive has made him a respected voice in the world of automotive development.With first-hand experience of the XJ-S from the inside, Ed brings invaluable perspective on what it took to turn Jaguar's grand touring vision into a reality — and how those lessons carried forward into his own engineering journey.As we celebrate 50 years of the Jaguar XJ-S, it's a pleasure to welcome Ed Abbott to share his memories, insights, and stories from an extraordinary career in engineering.

This week's Saturday Matinee on Vintage Classic Radio brings you a trio of classic broadcasts: in the Phil Harris-Alice Faye Show episode "Phil's Vaccination", Phil does everything he can to dodge a shot with predictably funny results; then Abbott and Costello lampoon the hardboiled detective genre in "Sam Shovel in the Caes of the Grocer Who Fell in Wet Cement"; and finally Orson Welles transports us into a world of whimsy and riddles with Columbia Workshop's imaginative adaptation of "Alice Through the Looking Glass".

Cincinnati Reds vs. Milwaukee Brewers MLB Pick Prediction by Tony T. Reds at Brewers 7:15 PM ET—Andrew Abbott will start for Cincinnati. Abbott got 28 starts with an ERA of 2.80 with WHIP of 1.16. The left hander fans 21.9% with 6.5% walks. Ground balls dealt at 31.4% with 1.01 home runs per nine innings. Jacob Misiorowski will be bulk pitcher for Milwaukee. Misiorowski appeared in fourteen games with an ERA of 4.38 and WHIP of 1.19. The right hander fans 32.3% with 10.8% walks. Grounders are 33.8% with 1.13 home runs per nine innings.

On this Salcedo Storm Podcast:Robert Montoya, Investigative reporter for texas Scorecard. 

Stories we're following this morning at Progress Texas:Federal and state authorities, who were quick to characterize Wednesday's shooting that killed or wounded three suspected undocumented immigrants as an attack on the ICE agents who had rounded them up, say they have found writings at the home of the suspected shooter confirming that he was targeting ICE: https://www.texastribune.org/2025/09/24/dallas-ICE-shooting-fatalities/...He is said to have acquired the rifle he used legally last month, and did not expect to survive the shooting: https://www.dallasobserver.com/news/joshua-jahns-handwritten-notes-revealed-plan-of-terror-40600292/...Journalist Ken Klippenstein believes the shooter was a product of a growing "irony bro" culture: https://www.kenklippenstein.com/p/the-ice-shooters-motivePublic Citizen has uncovered a "pay to play" scheme, under which big dollar donors to Governor Greg Abbott were awarded almost $1 billion in no-bid contracts over the last four years: https://www.citizen.org/news/public-citizen-report-abbott-donors-draw-nearly-1-billion-in-no-bid-state-contracts/The Texas Latino vote will be crucial in next year's mid-term election - and Texas Republicans are planning huge spending in pursuit of those votes: https://www.houstonpublicmedia.org/articles/news/politics/elections/2025/09/25/531917/texas-gop-set-to-push-back-on-democratic-organization-efforts-by-targeting-hispanic-voters/Christian Nationalist crusader David Barton has been appointed by the Texas State Board of Education as an expert advisor on new plans to refocus social studies curriculum towards U.S. history: https://www.texastribune.org/2025/09/24/texas-sboe-social-studies-standards-david-barton/Houston friends! Join Progress Texas in The Heights on Monday October 20 for our H-Town Hits Back live podcast taping event! Tickets and sponsorship opportunities are available now: ⁠⁠⁠⁠⁠⁠https://act.progresstexas.org/a/houston2025event⁠⁠⁠⁠⁠⁠Thanks for listening! Our monthly donors form the backbone of our funding, and if you're a regular, we'd like to invite you to join the team! Find our web store and other ways to support our important work at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://progresstexas.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Michael chats with Jennifer Jones-McMeans, Divisional Vice President of Global Clinical Affairs at Abbott's cardiovascular business. Together, they discuss what peripheral artery disease (PAD) is, warning signs of PAD, how PAD affects patient life, how to prevent the disease, treatment options, and much more. Learn more about PAD, symptoms, risks, and treatments at PAD-info.com.

Escucha el podcast del programa Sobre Ruedas con Harold Abbott a través de Súper 7 FM, en Santo Domingo, República Dominicana correspondiente al viernes 26-septiembre-2025.

Sydney Marathon beckoned as the newest World Marathon Major, and I couldn't resist answering the call after earning my six-star medal in Tokyo. This Australian adventure would become my seventh major—a milestone I never expected to reach when I started this journey.The electric atmosphere at the expo set the tone for the weekend, with volunteers and organizers proudly showcasing Sydney as the latest "world wonder" in the marathon circuit. Abbott created special photo opportunities for seven-star finishers, and I was thrilled to see strong female representation among participants. While the expo ran smoothly on day two, some logistical challenges emerged on race morning—most notably a 75-minute porto potty wait that left me rushing to my corral!Let me be crystal clear: Sydney offers the most challenging course among the majors, with significant hills in the later portions. The spectacular route winds through beautiful landscapes with perfect weather, culminating in that iconic finish at the Sydney Opera House. What Sydney currently lacks in crowd support compared to Chicago or New York, it compensates for with stunning scenery and strategic entertainment stations. Fellow runners considering this race should incorporate hill training at the end of long runs to prepare for those climbs on fatigued legs.Managing the 14+ hour time difference presented its own challenge. I fully committed to time-shifting protocols—even giving up caffeine despite Australia's amazing coffee culture! While not a perfect solution, these strategies helped me avoid illness despite extensive travel. The experience reinforced valuable lessons: you get the race you train for, preparation matters, and finish lines aren't endings but transitions to what comes next in our running journeys.Ready for your own extraordinary challenge? Join our October "Ghoul-Friend Gauntlet" in the Extraordinary League for accountability, connection, and a bit of spooky season fun. Drop into the Stride Collective to share what you're training for next, and keep making those extraordinary strides!Have questions or want to chat? Send me a text!Support the showJoin the newsletter list for updates, special offers, and exclusive behind-the-scenes content.Join fellow pod and running enthusiasts at The Stride Collective community on Facebook or follow us on Instagram.

This study examined outcomes of patients with atrial fibrillation treated with pulsed field ablation (PFA) and found a notably high incidence of phrenic nerve injury during the procedure. Most injuries were transient, but some persisted beyond the immediate peri-procedural period, raising concerns about long-term safety. The findings highlight the need for refined techniques and monitoring strategies to mitigate phrenic nerve injury risk with PFA. Please join host Michael S. Lloyd, MD, FHRS as he discusses the finding of this study with his guests Andrea M. Russo, MD, FHRS and Birju Rao, MD, Msci in Atlanta at the HRX Live 2025 conference. Learning Objective:  Examine outcomes of patients with atrial fibrillation treated with pulsed field ablation (PFA). Article AuthorsLouis Chéhirlian, MD, Linda Koutbi, MD, Julien Mancini, MD, PhD, Jérôme Hourdain, MD, Robin Richard-Vitton, MD, Marie Wilkin, MD, Jean-Claude Deharo, MD, Baptiste Maille, MD, PhD, Frédéric Franceschi, MD, PhD  Podcast Contributors Michael S. Lloyd, MD, FHRS | Emory University Andrea M. Russo, MD, FHRS | Cooper University Health Care Birju Rao, MD, Msci | Emory University Contributor Disclosure(s): M. Lloyd:   •Membership on Advisory Committees: Boston Scientific •Speaking/Teaching/Consulting: Medtronic, ArgaMedtech, Circa Scientific   B. Rao •Nothing relevant to disclose. A. Russo: •Honoraria/Speaking/Consulting: Pacemate, Abbott Medical, Medtronic, BiosenseWebster, Inc., AtriCure, Inc., Bayer Healthcare Pharmaceuticals, Boston Scientific •Research: Medtronic, Boston Scientific, Abbott, Bayer Healthcare Pharmaceuticals •Royalty Income: UpToDate,Inc. •Fellowship Support: Medtronic, Inc.   Bonus video of this episode, recorded at HRX Live 2025 in Atalnta, can be found on HRS365 and the HRX Innovation Hub.

Host: Susanna Price Guest: Robert Storey Want to watch that extended interview? Go to: https://esc365.escardio.org/event/2092?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.  Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Robert Storey has declared to have potential conflicts of interest to report: research grants and personal fees from AstraZeneca and Cytosorbents, and personal fees from Abbott, Afortiori Development/Thrombolytic Science, Boehringer Ingelheim/Lilly, Bristol Myers Squibb/Johnson & Johnson, Chiesi, Idorsia/Viatris, Novo Nordisk, PhaseBio and Tabuk. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers: Cardiology This Week: A concise summary of recent studies Strategic decisions in valvular heart disease Optimising drug therapy in chronic coronary syndromes Mythbusters: Does wearing a white coat make you smarter? Host: Susanna Price Guests: John-Paul Carpenter, Fabien Praz, Robert Storey Want to watch that episode? Go to: https://esc365.escardio.org/event/2092 Want to watch that extended interview on Optimising drug therapy in chronic coronary syndromes ? Go to: https://esc365.escardio.org/event/2092?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel, Fabien Praz and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Robert Storey has declared to have potential conflicts of interest to report: research grants and personal fees from AstraZeneca and Cytosorbents, and personal fees from Abbott, Afortiori Development/Thrombolytic Science, Boehringer Ingelheim/Lilly, Bristol Myers Squibb/Johnson & Johnson, Chiesi, Idorsia/Viatris, Novo Nordisk, PhaseBio and Tabuk. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Escucha el podcast del programa Sobre Ruedas con Harold Abbott a través de Súper 7 FM, en Santo Domingo, República Dominicana correspondiente al jueves 25-septiembre-2025.

Doug Abbott (CEO, Contrasted Marketing), who shares proven strategies on how to create powerful B2B messaging that converts.Doug discussed the importance of B2B marketers tailoring messaging to address the specific concerns, needs, and priorities of the different buying committee members.

Escucha el podcast del programa Sobre Ruedas con Harold Abbott a través de Súper 7 FM, en Santo Domingo, República Dominicana correspondiente al miércoles 24-septiembre-2025.

The news of Texas covered today includes:Our Lone Star story of the day: Lubbock County Commissioner Cary Shaw points out what few have wanted to let voters know:via facebook: Today [Monday] we finished the budget. Is it as low as I would like, no but it is a good start. For all the hollering about budget cuts I want everyone to know just what is going on. The budget has grown over 80,000,000 dollars in the past 5 years. That is 80 million. We keep being told a growing county has to have more money. Well during this time 1 year population growth was 1.3 percent and 3 years it was 1.2 percent, and 1 year it is projected to drop a hundred or so. At the rate it was going 16 million average per year 6 more years it would have doubled what it was in 2020. This is not sustainable for the people in Lubbock county. The judge said it is a sad day for Lubbock county but I say it is a great day for Lubbock county residents.” [emphasis added]Our Lone Star story of the day is sponsored by Allied Compliance Services providing the best service in DOT, business and personal drug and alcohol testing since 1995.Bob Albritton and other Texas A&M regents just will not stop pushing the Leftist agenda and reverse discrimination at A&M. Now, Aggies name a DEI supporter as acting-president for Texas A&M.Abbott's THC regulation is a mess: Senator Perry Requests State Agencies Create New Regulations on Hemp-Derived THC 21-Year Age Minimum for Purchasing THC Products Adopted by Texas Alcoholic Beverage Commission – only covers licensed booze sellers! Listen on the radio, or station stream, at 5pm Central. Click for our radio and streaming affiliates.www.PrattonTexas.com

I never thought you could earn from somebody else's settlements.But our guest today, Patrick Grimes, introduced us to another (“unique”, I would say) #alternativeinvestment that isn't mainstream yet.- AxelEpisode Takeaway and Action PlanEpisode Highlights:[00:00:00-00:02:06] From Tesla to Real Estate[00:02:07-00:04:24] Beyond the Stock Market[00:04:25-00:15:20] A Unique Opportunity with Legal Funding[00:15:21-00:19:29] Risks in Litigation Funding?[00:19:30-00:27:21] The Case for Diversification[00:27:22-00:31:23] How to Become a Litigation Investor[00:31:24-00:37:20] Behind the Scenes at SpaceX and TeslaSpecial Mentions:* Tesla, SpaceX, Bayer, Monsanto, Lockheed, Raytheon, Abbott, J&J, 3M, DuPont, Lessons from Thought Leaders by Patrick Grimes, Phil Collins, Def Leppard, Kevin Eastman, Zig Ziglar, and Brian Tracy* Cases mentioned: Camp Lejeune water contamination, LA Juvenile Detention Center sexual assault, Roundup/paraquat lawsuits, toxic baby formula***Start taking action right NOW! 

Pollster Brannon Miller, City Hall reporter Molly Smith and host Greg Jefferson discuss the campaign for tax dollars for a Spurs arena, why Gov. Greg Abbott has spooked big-name Democratic challengers and Mayor Gina Ortiz Jones' first 100 days. Suggested reading: Why Texas Democrats aren't lining up to take on Greg Abbott in the midterms Sources: Ron Nirenberg weighing run for governor or county judge What is Bexar County getting for helping the Spurs pay for an arena? Sign up here for our ENside Politics newsletter: https://www.expressnews.com/newsletters/ensidepolitics/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Austinites and Texans overwhelmingly support keeping consumable hemp products legal, even after the Texas Legislature focused its sights on addressing the state's largely unregulated THC market. But after Gov. Greg Abbott vetoed the THC ban that lawmakers passed during the regular session — and subsequent attempts in the first and second special sessions also failed — where exactly did we land on what's legal to use and sell in town? (Spoiler alert: No more disposable vapes.) And after Gov. Abbott's executive order that stopped minors from purchasing any consumable hemp products, could other regulations be coming? Host Nikki DaVaughn is joined by Mary Jae cannabis dispensary co-owner Jae Graham-Anciso and Heather Fazio, director of the Texas Cannabis Policy Center, to get into the weeds on the latest on consumable hemp.  Want some more Austin news? Then make sure to sign up for our Hey Austin newsletter.  And don't forget– you can support this show and get great perks by becoming a City Cast Austin Neighbor at membership.citycast.fm  Follow us @citycastaustin You can also text us or leave a voicemail.  Interested in advertising with City Cast? Find more info HERE earn more about the sponsors of this September 22nd episode: Wise Babbel - Get up to 60% off at Babbel.com/CITYCAST LBJ Presidential Library

I never thought you could earn from somebody else's settlements. But our guest today, Patrick Grimes, introduced us to another (“unique”, I would say) #alternativeinvestment that isn't mainstream yet.Episode Deep Dive with Action Plan: https://tinyurl.com/ep-joe-tegtmeyerEpisode Highlights:[00:00:00-00:02:06] From Tesla to Real Estate[00:02:07-00:04:24] Beyond the Stock Market[00:04:25-00:15:20] A Unique Opportunity with Legal Funding[00:15:21-00:19:29] Risks in Litigation Funding?[00:19:30-00:27:21] The Case for Diversification[00:27:22-00:31:23] How to Become a Litigation Investor[00:31:24-00:37:20] Behind the Scenes at SpaceX and TeslaSpecial Mentions:Tesla, SpaceX, Bayer, Monsanto, Lockheed, Raytheon, Abbott, J&J, 3M, DuPontLessons from Thought Leaders by Patrick Grimes, Phil Collins, Def Leppard, Kevin Eastman, Zig Ziglar, and Brian TracyCases mentioned: Camp Lejeune water contamination, LA Juvenile Detention Center sexual assault, Roundup/paraquat lawsuits, toxic baby formula***Start taking action right NOW! 

SummaryIn this episode Kimberly Snyder speaks with Henry Abbott, a former ESPN journalist and physical movement expert, discussing his new book 'Ballistic: The New Science of Injury-Free Athletic Performance.' They explore the importance of heart-led living, the connection between movement and emotional well-being, and the significance of understanding our body's mechanics to prevent injuries. The conversation emphasizes the need for diverse movement practices, the role of weightlifting, and the impact of hydration and nutrition on overall health. Abbott shares insights on how to improve mobility and stability, particularly focusing on the hips, and the importance of trusting our bodies to move freely and joyfully.SPONSORS: LMNTOFFER: Right now, for my listeners LMNT is offering a free sample pack with any LMNT drink mix purchase at DrinkLMNT.com/FEELGOOD. That's 8 single serving packets FREE with any LMNT any LMNT drink mix purchase. This deal is only available through my link so. Also try the new LMNT Sparkling — a bold, 16-ounce can of sparkling electrolyte water.USE LINK: DrinkLMNT.com/FEELGOODFATTY15OFFER: Fatty15 is on a mission to replenish your C15 levels and restore your long-term health. You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/KIMBERLY and using code KIMBERLY at checkout.USE LINK: fatty15.com/KIMBERLYChapters00:00 Heart-Led Living and Wellness Introduction00:53 Exploring Athletic Performance and Injury Prevention03:06 The Importance of Connection to Movement05:42 Understanding Movement Patterns and Injury Risks09:01 The Role of Hips in Mobility and Stability12:00 Weightlifting and Its Benefits for Women15:00 Hydration and Nutrition for Optimal Performance17:38 The Science of Movement and Body Awareness20:50 Fascial Release and Its Impact on Mobility23:31 The Interconnection of Physical and Emotional Health26:35 Embracing Diverse Movement Practices29:31 The Role of Animals in Understanding Movement32:41 Conclusion and Call to ActionSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.